Outsmarting Pathogens with Antibody Engineering.
Annu Rev Chem Biomol Eng
; 14: 217-241, 2023 06 08.
Article
en En
| MEDLINE
| ID: mdl-36917814
There is growing interest in identifying antibodies that protect against infectious diseases, especially for high-risk individuals and pathogens for which no vaccine is yet available. However, pathogens that manifest as opportunistic or latent infections express complex arrays of virulence-associated proteins and are adept at avoiding immune responses. Some pathogens have developed strategies to selectively destroy antibodies, whereas others create decoy epitopes that trick the host immune system into generating antibodies that are at best nonprotective and at worst enhance pathogenesis. Antibody engineering strategies can thwart these efforts by accessing conserved neutralizing epitopes, generating Fc domains that resist capture or degradation and even accessing pathogens hidden inside cells. Design of pathogen-resistant antibodies can enhance protection and guide development of vaccine immunogens against these complex pathogens. Here, we discuss general strategies for design of antibodies resistant to specific pathogen defense mechanisms.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Vacunas
/
Anticuerpos Neutralizantes
Límite:
Humans
Idioma:
En
Revista:
Annu Rev Chem Biomol Eng
Año:
2023
Tipo del documento:
Article
Pais de publicación:
Estados Unidos